GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » Tianjin TEDA Biomedical Engineering Co Ltd (HKSE:08189) » Definitions » 5-Year ROIIC %

Tianjin TEDA Biomedical Engineering Co (HKSE:08189) 5-Year ROIIC % : -132.84% (As of Dec. 2023)


View and export this data going back to 2002. Start your Free Trial

What is Tianjin TEDA Biomedical Engineering Co 5-Year ROIIC %?

5-Year Return on Invested Incremental Capital (5-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 5-year. Tianjin TEDA Biomedical Engineering Co's 5-Year ROIIC % for the quarter that ended in Dec. 2023 was -132.84%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for Tianjin TEDA Biomedical Engineering Co's 5-Year ROIIC % or its related term are showing as below:

HKSE:08189's 5-Year ROIIC % is ranked worse than
96.67% of 240 companies
in the Agriculture industry
Industry Median: 3.405 vs HKSE:08189: -132.84

Tianjin TEDA Biomedical Engineering Co 5-Year ROIIC % Historical Data

The historical data trend for Tianjin TEDA Biomedical Engineering Co's 5-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tianjin TEDA Biomedical Engineering Co 5-Year ROIIC % Chart

Tianjin TEDA Biomedical Engineering Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
5-Year ROIIC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 86.03 28.95 3.41 -132.84 -

Tianjin TEDA Biomedical Engineering Co Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Jun24 Dec24
5-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - -132.84 - -

Competitive Comparison of Tianjin TEDA Biomedical Engineering Co's 5-Year ROIIC %

For the Agricultural Inputs subindustry, Tianjin TEDA Biomedical Engineering Co's 5-Year ROIIC %, along with its competitors' market caps and 5-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tianjin TEDA Biomedical Engineering Co's 5-Year ROIIC % Distribution in the Agriculture Industry

For the Agriculture industry and Basic Materials sector, Tianjin TEDA Biomedical Engineering Co's 5-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where Tianjin TEDA Biomedical Engineering Co's 5-Year ROIIC % falls into.


;
;

Tianjin TEDA Biomedical Engineering Co 5-Year ROIIC % Calculation

Tianjin TEDA Biomedical Engineering Co's 5-Year ROIIC % for the quarter that ended in Dec. 2023 is calculated as:

5-Year ROIIC %=5-Year Incremental Net Operating Profit After Taxes (NOPAT)**/5-Year Incremental Invested Capital**
=( -9.8222167 (Dec. 2023) - -67.031499 (Dec. 2018) )/( 315.719 (Dec. 2023) - 358.784 (Dec. 2018) )
=57.2092823/-43.065
=-132.84%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Annual data of NOPAT and Invested Capital was used to calculate 5-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


Tianjin TEDA Biomedical Engineering Co  (HKSE:08189) 5-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


Tianjin TEDA Biomedical Engineering Co 5-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of Tianjin TEDA Biomedical Engineering Co's 5-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Tianjin TEDA Biomedical Engineering Co Business Description

Traded in Other Exchanges
N/A
Address
No. 80, The 4th Avenue, 9th Floor, Block A2, Tianda Hi-Tech Park, TEDA Tianjin, Tianjin, CHN
Tianjin TEDA Biomedical Engineering Co Ltd is engaged in the research, development, and commercialization of biological compound fertilizers, providing elderly and health care services. It operates in two segments namely; biological compound fertilizers products, and elderly care and health care services. The company generates a majority of its revenue from the Fertilisers products segment which is engaged in manufacturing and selling biological compound fertiliser products, including active fertiliser, mixture with nitrogen, phosphorus, and potassium with various formulas, providing warehousing services, and processing and licensing of the fertiliser products. The People's Republic of China is the primary geographical market for the company.
Executives
Long Ortiz 2101 Beneficial owner

Tianjin TEDA Biomedical Engineering Co Headlines

No Headlines